Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of antineoplaston therapy for Stage IV adrenocortical carcinoma was terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• Antineoplaston AS-2-1 (AS-2-1)

Snippet

Sponsor: Burzynski Research Institute | Conditions: Stage IV Adrenocortical Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2018-05-09